Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study

Vandersmissen, Godelieve; Moens, Guido; Vranckx, Robert; de Schryver, Antoon; Jacques, Pierre
September 2000
Occupational & Environmental Medicine;Sep2000, Vol. 57 Issue 9, p621
Academic Journal
Presents a study to assess the prevalence of varicella zoster virus antibodies in Belgian healthcare workers. Association between seronegativity and selected variables; Increase in seronegativity among people above the age of 45 years.


Related Articles

  • Case Report: Occupationally Related Recurrent Varicella (Chickenpox) in a Hospital Nurse. Chih-Hung Ku; Yu-Tien Liu; Christiani, David C. // Environmental Health Perspectives;Oct2005, Vol. 113 Issue 10, p1373 

    Commonly accepted outcomes of varicella-zoster virus (VZV) infections include chickenpox (primary) and shingles (recurrence or latency), as well lifetime immunity against chickenpox. We report the case of a registered nurse who worked in a neurologic surgery ward in a general hospital in...

  • Literature reviews. Rowland, P; Wald, ER // Clinical Pediatrics;Dec1995, Vol. 34 Issue 12, p668 

    Looks at the effect and complication of varicella zoster virus (VZV) infections in immunocompromised patients. Results of VZV in children with acute lymphoblastic leukemia; Reported cases of chickenpox in United States.

  • Vaccine added to immunization schedule.  // Dermatology Times;Mar1996, Vol. 17 Issue 3, p88 

    Reports that Merck's varicella-zoster virus vaccine has been added to the recommended childhood immunization schedule.

  • Management and prevention of varicella-zoster.  // Patient Care;12/15/1997, Vol. 31 Issue 20, p31 

    Presents information as it relates to varicella-zoster virus, which is responsible for a large number of hospitalizations and deaths in the United States, while highlighting some of the ways in which the virus can be managed and prevented. Reference to some of the diseases which occur as a...

  • Treat VZV early in HIV-infected patients. Sabbagh, Leslie // Dermatology Times;Sep95, Vol. 16 Issue 9, p3 

    Reports that the treatment for varicella-zoster virus in the immunnocompromised host should be started early to quell symptoms and prevent postherpetic neuralgia. Risk for HIV infection; Treatment using foscarnet.

  • Unintended Administration of Varicella Vaccine.  // American Family Physician;3/1/1997, Vol. 55 Issue 4, p1462 

    Discusses a report which deals with unintentional administration of varicella vaccine to pregnant women. Details on the report; Number of reported cases of women who received the vaccine.

  • Varicella-zoster virus infection.  // MMWR: Morbidity & Mortality Weekly Report;6/27/1997 Supplement RR-12, Vol. 46, p25 

    Provides information on varicella-zoster infection. How exposure to this disease can be prevented; Way in which the disease can be prevented; What is necessary to hinder recurrence; Precautions that should be taken by children and pregnant women.

  • The Congenital Varicella Syndrome. Sauerbrei, Andreas; Wutzler, Peter // Journal of Perinatology;Dec2000, Vol. 20 Issue 8, p548 

    Maternal varicella during the first two trimesters of pregnancy may cause the congenital variella syndrome (CVS). After infection in the first 20 weeks' gestation, the incidence is estimated to be about 2%. To date, nearly 100 infants born with signs of CVS have been reported in the literature,...

  • Varicella vaccine could be effective zoster prophylactic for older patients. Clark, Jennifer // Dermatology Times;Sep2002, Vol. 23 Issue 9, p48 

    Examines the efficacy of varicella vaccine in preventing cella-zoster virus infection in older patients. Development of zoster following hematopoietic cell transplant; Risk of children to redevelop the disease due to decreased immunities; Benefit of the varicella vaccine on the transplant.


Read the Article


Sign out of this library

Other Topics